Trinity Biotech (TRIB) Income towards Parent Company (2016 - 2024)
Historic Income towards Parent Company for Trinity Biotech (TRIB) over the last 16 years, with Q4 2024 value amounting to -$16.2 million.
- Trinity Biotech's Income towards Parent Company fell 19382.72% to -$16.2 million in Q4 2024 from the same period last year, while for Jun 2025 it was -$27.9 million, marking a year-over-year decrease of 2512.22%. This contributed to the annual value of -$31.8 million for FY2024, which is 3240.07% down from last year.
- Latest data reveals that Trinity Biotech reported Income towards Parent Company of -$16.2 million as of Q4 2024, which was down 19382.72% from -$4.8 million recorded in Q3 2024.
- In the past 5 years, Trinity Biotech's Income towards Parent Company ranged from a high of $10.7 million in Q3 2020 and a low of -$18.6 million during Q2 2023
- Moreover, its 5-year median value for Income towards Parent Company was -$5.2 million (2023), whereas its average is -$4.2 million.
- Its Income towards Parent Company has fluctuated over the past 5 years, first soared by 43611.89% in 2020, then crashed by 203149.91% in 2022.
- Over the past 5 years, Trinity Biotech's Income towards Parent Company (Quarter) stood at $9.6 million in 2020, then crashed by 136.75% to -$3.5 million in 2021, then plummeted by 207.43% to -$10.8 million in 2022, then soared by 49.0% to -$5.5 million in 2023, then tumbled by 193.83% to -$16.2 million in 2024.
- Its Income towards Parent Company was -$16.2 million in Q4 2024, compared to -$4.8 million in Q3 2024 and -$6.9 million in Q2 2024.